BRAND NAME: CYTOXAN
HOW THIS MEDICATION WORKS
Cyclophosphamide is a serious drug used to treat very serious disease. One uses cyclophosphamide to kill cells that are causing harm, usually cancer cells or inflammatory cells.
This potent cell-killing medication is a “nitrogen mustard” derivative, meaning it is related to the toxic chemical weapon “mustard gas” (so named because of its “mustard” or “horseradish” odor) used widely in the first World War. In chemotherapy, cyclophosphamide is classified as an “alkylating agent” which means it works by binding to DNA, and interfering with normal cell function. By disrupting cellular DNA, cyclophosphamide is able to kill the cell. Cells that divide rapidly (and thus replicate their DNA rapidly) are especially targeted by cyclophosphamide. This makes cyclophosphamide especially able to kill:
USES OF THIS MEDICATION
Because of its ability to kill rapidly dividing, cyclophosphamide has been used most successfully in two situations:
More recently, "metronomic" chemotherapy has emerged as a cancer treatment method. In metronomic chemotherapy, small doses of drugs are used daily. This minimizes drug side effects and presents the tumor with a daily attack, keeping it at bay. Cyclophosphamide and piroxicam are used together to address some sarcomas in dogs as a means of addressing the tumor with reduced potential for the side effects listed below.
There are several important side effects to consider when using cyclophosphamide:
Bone Marrow Suppression
White cell blood lines show suppression (i.e. counts will drop) approximately 1-2 weeks following a dose of cyclophosphamide. This time period makes the patient especially vulnerable to infection. Many oncologists like to monitor white blood cell count and withhold cyclophosphamide if the white blood cell count is not greater than a certain minimum number. Other oncologists do not like to reduce the cyclophosphamide dose without evidence of infection as reducing the cyclophosphamide dose will give the tumor an advantage and possibly jeopardize the remission.
While human chemotherapy patients commonly lose their hair, animal patients almost never do. The exceptions are wavy coated dogs such as poodles and Old English Sheepdogs). Cats undergoing chemotherapy commonly lose their whiskers. Hair texture on pets in general tends to get softer on chemotherapy.
Despite the image most people have of nausea associated with chemotherapy, this is actually a surprisingly uncommon problem in dogs and cats. When it occurs, it is generally readily controllable with antinauseal medications.
Development of Hemorrhagic Cystitis
Up to 30% of dogs (depending on the study) receiving cyclophosphamide for over 2 months develop bloody urine caused by excretion of irritating cyclophophamide metabolites. This condition may represent pre-cancer in itself and must be distinguished from a bladder infection. This is a serious side effect of cyclophosphamide use and any sign of bloody urine should be reported to the veterinarian at once. Hemorrhagic cystitis is much rarer in cats but is still as serious when it arises.
INTERACTIONS WITH OTHER DRUGS
Special consideration should be used when cyclophosphamide is given to patients taking additional medications with bone marrow suppressing potential. Examples of such medications include azathioprine, chlorambucil, or methimazole). Additional monitoring tests may be recommended.
Phenobarbital will increase the rate of excretion of cyclophosphamide (i.e. cyclophosphamide will be more rapidly removed from the body). This will increase the toxicity potential of the cyclophosphamide. Conversely, the antibiotic chloramphenicol may reduce the metabolism of cyclophosphamide thereby increasing its potency.
Diuretics of the thiazide class may increase the bone marrow suppression side effects of cyclophosphamide. Allopurinol, a medication used to reduce uric acid crystal deposits, can also increase the bone marrow suppression side effects of cyclophosphamide.
Ondansetron, a nausea medication, may reduce the strength and efficacy of cyclophosphamide and cyclosporine, an immunomodulator, may decrease cyclophosphamide levels and weaken its strength.
CONCERNS AND CAUTIONS
Obviously it is not prudent to suppress the immune system in the face of a known infection.
Cyclophosphamide is toxic to the unborn fetus and should not be used in pregnancy.
The majority of cyclophosphamide is excreted in urine and a dose is still detectable in urine some 72 hours after administration.
Due to the unique manufacture of cyclophosphamide tablets, these tablets cannot be accurately dosed after being cut. It is best to use tablets whole.
If cyclophosphamide is administered at home, it is important that gloves are worn when handling.
Page last updated: 2/5/2016